All companies, by market cap
505 companies and 2079 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Revenue | Quarter |
|---|---|---|---|---|---|
| 326 |
|
$110B | $276.63 +3.1% | $21.9B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 ADP Automatic Data Processing |
| 327 |
|
$110B | $382.95 −1.9% | $139.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 VLO Valero Energy |
| 328 |
|
$111B | $198.17 +0.7% | $90.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 LOW Lowe's |
| 329 |
|
$111B | $396.45 +0.1% | $153.6B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 MPC Marathon Petroleum |
| 330 | APP S&P 500 AppLovin Position 330 S&P 500 Share price: $334.24 +3.2% Q2 FY26 APP AppLovin | $112B | $334.24 +3.2% | $6.8B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 APP AppLovin |
| 331 |
|
$113B | $99.07 +0.3% | $38.3B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 SBUX Starbucks |
| 332 |
|
$117B | $928.83 −2.3% | $21.5B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 PH Parker Hannifin |
| 333 |
|
$118B | $70.61 +2.4% | $23.5B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 MO Altria |
| 334 |
|
$120B | $93.80 +3.1% | $37.5B Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 MDT Medtronic |
| 335 |
|
$122B | $529.38 +1.0% | $77.0B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 LMT Lockheed Martin |
| 336 |
|
$122B | $95.55 +0.9% | $312.2B 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 | Q2 FY26 CVS CVS Health |
| 337 |
|
$124B | $143.60 −13.7% | $16.3B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 GLW Corning |
| 338 |
|
$125B | $170.18 +9.0% | $7.5B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 FTNT Fortinet |
| 339 |
|
$127B | $206.68 −0.8% | $46.2B 3 of four quarters in a row 2026: Q1 · 2025: Q3, Q4 | Q1 FY26 COF Capital One |
| 340 |
|
$130B | $123.07 −2.9% | $25.8B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 NEM Newmont |
| 341 |
|
$130B | $195.00 +6.0% | $73.1B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 ACN Accenture |
| 342 |
|
$131B | $64.10 +0.7% | $24.5B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 BMY Bristol Myers Squibb |
| 343 |
|
$132B | $519.51 +0.8% | $12.6B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 VRTX Vertex Pharmaceuticals |
| 344 |
|
$132B | $175.35 +0.8% | $28.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 BKNG Booking |
| 345 |
|
$134B | $377.94 +2.4% | $11.0B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ISRG Intuitive Surgical |
| 346 |
|
$139B | $125.99 +0.0% | $29.5B 2 of four quarters in a row 2027: Q1, Q2 | Q2 FY27 TJX TJX Companies |
| 347 |
|
$143B | $203.25 +1.6% | $25.1B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 DHR Danaher |
| 348 |
|
$147B | $142.35 +7.4% | $14.7B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 NOW ServiceNow |
| 349 |
|
$148B | $72.63 +1.3% | $55.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 UBER Uber |
| 350 |
|
$153B | $393.16 −7.6% | $16.0B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 ETN Eaton |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.